Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krajewska, M.
Right arrow Articles by Krajewski, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krajewska, M.
Right arrow Articles by Krajewski, S.
Clinical Cancer Research Vol. 11, 5462-5471, August 1, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Tumor-Associated Alterations in Caspase-14 Expression in Epithelial Malignancies

Maryla Krajewska1, Hoguen Kim2, Eunah Shin2, Susan Kennedy3, Michael J. Duffy4, Yick F. Wong5, David Marr6, Jowita Mikolajczyk1, Ahmed Shabaik7, Ivo Meinhold-Heerlein8, Xianshu Huang1, Steven Banares1, Hirad Hedayat1, John C. Reed1 and Stan Krajewski1

Authors' Affiliations: 1 The Burnham Institute, La Jolla, California; 2 College of Medicine, Yonsei University, Seoul, Korea; 3 Royal Victoria Eye and Ear Hospital, Dublin, Ireland; 4 St. Vincent's University Hospital, Department of Surgery, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; 5 The Chinese University of Hong Kong, Prince of Wales Hospital, Department of Obstetrics and Gynaecology, Hong Kong, China; 6 Applied Imaging Corporation, San Jose, California; 7 Department of Pathology, University of California-San Diego, California; and 8 Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Kiel, Germany

Requests for reprints: Stan Krajewski, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3663; Fax: 858-646-3194; E-mail: reedoffice{at}burnham.org.

Purpose: Caspase-14 is unique among caspase family proteases in that its proteolytic processing has been principally associated with epithelial cell differentiation rather than apoptosis or inflammation. We investigated caspase-14 expression in several types of human epithelial malignancy by immunohistochemistry, correlating results with stage, histologic grade, and patient survival.

Experimental Design: Tumor-associated alterations in caspase-14 expression were observed for cervical, ovarian, breast, gastric, and colon cancers.

Results: In cervical (n = 445), ovarian (n = 91), and colon (n = 106) specimens, expression of caspase-14 was significantly reduced in cancers compared with normal epithelium. Decreases in caspase-14 immunopositivity correlated with the histologic progression of cervical cancer (P < 0.0001, ANOVA). In localized gastric cancers, caspase-14 immunostaining was significantly lower in poorly differentiated tumors compared with well-differentiated tumors (P = 0.02, Pearson's {chi}2 analysis). Lower caspase-14 expression was associated with advanced clinical stage in ovarian cancer (P = 0.04, ANOVA) and with shorter overall survival among ovarian cancer patients with serous tumors (n = 62) in both univariate (P = 0.005) and multivariate (P = 0.03) analysis. Lower caspase-14 expression correlated with shorter overall survival among patients with T3N0M0 stage gastric cancers (n = 94; P = 0.006, log-rank test). In contrast to cervical, ovarian, and colon cancers, caspase-14 expression was increased in ductal carcinoma in situ and invasive cancers compared with normal mammary epithelium (P = 0.001, t test).

Conclusions: The findings reveal tumor-specific alterations in caspase-14 expression and suggest that differences in its expression may define subsets of epithelial cancers with distinct clinical behaviors.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Krajewska, S. Kitada, J. N. Winter, D. Variakojis, A. Lichtenstein, D. Zhai, M. Cuddy, X. Huang, F. Luciano, C. H. Baker, et al.
Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies
Clin. Cancer Res., May 15, 2008; 14(10): 3011 - 3021.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
G. Denecker, P. Ovaere, P. Vandenabeele, and W. Declercq
Caspase-14 reveals its secrets
J. Cell Biol., February 6, 2008; 180(3): 451 - 458.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Luciano, M. Krajewska, P. Ortiz-Rubio, S. Krajewski, D. Zhai, B. Faustin, J.-M. Bruey, B. Bailly-Maitre, A. Lichtenstein, S. K. Kolluri, et al.
Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma
Blood, May 1, 2007; 109(9): 3849 - 3855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.